Use of the drug aleglitazar has shown the ability to lower glucose levels and have favorable effects on cholesterol. It did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a iJAMA/i study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. Cardiovascular disease remains the dominant ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/1jMaRtZ
No comments:
Post a Comment